Erythropoietin-Derived Peptide | Anti-Inflammatory & Neuropathic Research | For Research Use Only

ARA-290 is a synthetic non-erythropoietic peptide derived from erythropoietin (EPO) that selectively binds to the innate repair receptor (IRR), not the erythropoietin receptor responsible for red blood cell production. This makes it highly valuable in research focused on neuropathic pain, tissue repair, autoimmune modulation, and inflammatory diseases.

It has shown potential in models of diabetes-related neuropathy, kidney protection, and chronic inflammatory conditions, all without raising hematocrit levels or stimulating erythropoiesis.

🔍 Key Features

• Selective IRR Activation – Promotes tissue repair without affecting red blood cell count

• Anti-Inflammatory – Reduces inflammatory cytokines and supports immune modulation

• Neuroprotective – Studied in peripheral neuropathy, especially diabetic-induced

• Supports Renal & Cardiovascular Research – Protective effects in ischemic injury models

• Non-Erythropoietic – Safe for long-term metabolic and inflammatory studies

⚙️ Peptide Details

• Peptide Name: ARA-290 (Cibinetide)

• CAS Number: 75558-67-5

• Molecular Formula: C₁₄₄H₂₄₄N₄₂O₃₈

• Molecular Weight: ~3297.7 g/mol

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised white/off-white powder

• Unit Size: 10mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20°C in a dry, light-protected container

• Reconstitution: Use bacteriostatic water or sterile saline

• Post-Reconstitution: Store at 2–8°C and use within 5–7 days

• Avoid: Repeated freeze-thaw cycles

⚠️ For Research Use Only

ARA-290 – 10mg is provided strictly for laboratory research. It is not intended for human or veterinary use, diagnosis, or treatment. Must be handled by qualified researchers under institutional safety protocols.